Results 201 to 210 of about 79,367 (221)

Thrombotic thrombocytopenic purpura

Blood Coagulation & Fibrinolysis, 1992
Thrombotic thrombocytopenic purpura is an uncommon disorder, but it continues to be of considerable interest. The disease mechanisms are unclear and the aetiology is unknown. Perhaps most enigmatic of all, the mode of action of plasma therapy, which successfully induces remission in about two-thirds of cases, is wholly inexplicable. There are currently
Theodore E. Warkentin, William G. Murphy, Jane C. Moore, Catherine P.M. Hayward, John G. Kelton   +4 more
openaire   +3 more sources

Idiopathic Thrombocytopenic Purpura

Primary Care: Clinics in Office Practice, 1980
The finding of thrombocytopenia with normal or increased megakaryocytes on bone marrow aspirate supports the diagnosis of ITP. It is essential, however, that every effort be made to exclude other causes of the consumption of platelets. Most cases of chronic ITP are immune in origin; consequently, steroid therapy is the initial treatment of choice ...
openaire   +3 more sources

Autoimmune Thrombocytopenic Purpura

Hematology/Oncology Clinics of North America, 1990
The classic therapies of ITP are corticosteroids and splenectomy. These therapies will suffice to treat the majority of patients. In any patient with ITP in whom an urgent rise in the platelet count is required, especially children with acute ITP at diagnosis, gammaglobulin in combination with corticosteroids is very effective.
openaire   +3 more sources

Thrombocytopenic purpura

Oral Surgery, Oral Medicine, Oral Pathology, 1959
R J, ENGLERT, H N, PASQUAL, M, LITT
openaire   +2 more sources

Human medicines European public assessment report (EPAR): Privigen, human normal immunoglobulin (IVIg), Purpura, Thrombocytopenic, Idiopathic,Bone Marrow Transplantation,Immunologic Deficiency Syndromes,Guillain-Barre Syndrome,Mucocutaneous Lymph Node Syndrome, Date of authorisation: 24/04/2008, Rev

Case Medical Research, 2019

semanticscholar   +1 more source

Human medicines European public assessment report (EPAR): Nplate, romiplostim, Purpura, Thrombocytopenic, Idiopathic, Date of authorisation: 04/02/2009, Revision: 21, Status: Authorised

Case Medical Research, 2019

semanticscholar   +1 more source

Human medicines European public assessment report (EPAR): Flebogamma DIF (previously Flebogammadif), human normal immunoglobulin, Mucocutaneous Lymph Node Syndrome,Guillain-Barre Syndrome,Bone Marrow Transplantation,Purpura, Thrombocytopenic, Idiopathic,Immunologic Deficiency Syndromes, Date of auth

Case Medical Research, 2019

semanticscholar   +1 more source

Human medicines European public assessment report (EPAR): Kiovig, human normal immunoglobulin, Purpura, Thrombocytopenic, Idiopathic,Bone Marrow Transplantation,Immunologic Deficiency Syndromes,Guillain-Barre Syndrome,Mucocutaneous Lymph Node Syndrome, Date of authorisation: 18/01/2006, Revision: 21

Case Medical Research, 2019

semanticscholar   +1 more source

Human medicines European public assessment report (EPAR): Kiovig, human normal immunoglobulin, Purpura, Thrombocytopenic, Idiopathic,Bone Marrow Transplantation,Immunologic Deficiency Syndromes,Guillain-Barre Syndrome,Mucocutaneous Lymph Node Syndrome, Date of authorisation: 18/01/2006, Revision: 23

Case Medical Research, 2019

semanticscholar   +1 more source

Human medicines European public assessment report (EPAR): Revolade, eltrombopag, Purpura, Thrombocytopenic, Idiopathic, Date of authorisation: 11/03/2010, Revision: 23, Status: Authorised

Case Medical Research, 2019

semanticscholar   +1 more source